Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Balzarotti

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
American Journal of Hematology|February 28, 2015
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell LymphomaLuca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
Gastrointestinal Endoscopy|March 29, 2023
Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter seriesSilvia Carrara, Daoud Rahal, Kareem Khalaf, et al.
American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Haematologica|November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersFrancesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
Annals of Hematology|February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
Haematologica|July 25, 2015
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patientsRoberto Crocchiolo, Luca Castagna, Sylvain Garciaz, et al.
British Journal of Haematology|January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|May 3, 2016
The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma)Stephane Chauvie, Fabrizio Bergesio, Federica Fioroni, et al.
American Journal of Hematology|February 28, 2015
The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL)Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, et al.
International Journal of Radiation Oncology, Biology, Physics|November 15, 2016
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell LymphomaLuca Ceriani, Maurizio Martelli, Maria K Gospodarowicz, et al.
Gastrointestinal Endoscopy|March 29, 2023
Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter seriesSilvia Carrara, Daoud Rahal, Kareem Khalaf, et al.
American Journal of Hematology|October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana LinfomiGiuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Haematologica|November 8, 2011
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkersFrancesco Zaja, Stefano De Luca, Umberto Vitolo, et al.
British Journal of Haematology|December 24, 2021
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trialAnnalisa Chiappella, Fary Diop, Claudio Agostinelli, et al.
Annals of Hematology|February 22, 2012
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL)Luigi Rigacci, Benedetta Puccini, Sergio Cortelazzo, et al.
Haematologica|July 25, 2015
Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patientsRoberto Crocchiolo, Luca Castagna, Sylvain Garciaz, et al.
British Journal of Haematology|January 21, 2021
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL)Carola Boccomini, Marco Ladetto, Luigi Rigacci, et al.
Pageof 8